Investor Schonfeld Strategic Advisors LLC
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Schonfeld Strategic Advisors LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-08-14 13G/A MRSN / Mersana Therapeutics, Inc. 7,614,065 5,673,852
2025-08-14 13G/A FATE / Fate Therapeutics, Inc. 7,794,513 937,521
2025-08-14 13G/A SKYE / Skye Bioscience, Inc. 1,617,697 1,115,939
2025-05-15 13G/A TERN / Terns Pharmaceuticals, Inc. 5,234,508 4,305,204
2025-05-15 13G MRSN / Mersana Therapeutics, Inc. 7,614,065
2025-05-15 13G/A APLT / Applied Therapeutics, Inc. 8,769,640 4,676,097
2025-05-15 13G FATE / Fate Therapeutics, Inc. 7,794,513
2025-05-15 13G SKYE / Skye Bioscience, Inc. 1,617,697
2025-02-14 13G/A RVPH / Reviva Pharmaceuticals Holdings, Inc. 1,772,715 1,314,915
2025-02-14 13G/A TERN / Terns Pharmaceuticals, Inc. 5,234,508
2025-02-14 13G APLT / Applied Therapeutics, Inc. 8,769,640
2024-11-14 13G RVPH / Reviva Pharmaceuticals Holdings, Inc. 1,772,715
2024-02-14 13G/A CYCC / Cyclacel Pharmaceuticals, Inc. 770,400 1,900
2024-02-14 13G/A GCMG / GCM Grosvenor Inc. 3,588,716 41,993
2023-02-14 13G/A GCMG / GCM Grosvenor Inc. 4,710,473 3,588,716
2023-02-14 13G CYCC / Cyclacel Pharmaceuticals, Inc. 770,400
2023-02-14 13G/A MKTW / MarketWise, Inc. 1,468,900 0
2022-06-09 13G/A GCMG / GCM Grosvenor Inc. 2,624,360 4,710,473
2022-02-15 13G MKTW / MarketWise, Inc. 1,468,900
2022-02-14 13G GCMG / GCM Grosvenor Inc. 2,624,360
2022-02-14 13G/A CCV / Churchill Capital Corp V - Class A 16,518
2022-02-14 13G/A PUBM / PubMatic, Inc. 442,200 517,926
2021-02-16 13G CCV.U / Churchill Capital Corp V Units, each consisting of one share of Class A common stock, and one-fourth 2,520,000
2021-02-16 13G PUBM / PubMatic, Inc. 442,200
2021-02-16 13G/A CLW / Clearwater Paper Corporation 835,014 201,189
2020-02-14 13G CLW / Clearwater Paper Corporation 835,014